The Trump administration is proceeding with probes into the national security implications of pharmaceutical imports.

The Dark Secrets of Johnson & Johnson.” Gardiner Harris, a former pharmaceutical reporter for The New York Times and a reporter for The Wall Street Journal, effectively explains the legal battles ...

While AbbVie handily beat expectations this quarter, the company faces declining Humira sales and a challenged aesthetics ...

Breast Health — Recognizing the high proportion of local women with dense breast tissue, Johnson County Hospital invested in ...

The bone graft incorporating rhBMP-2 has received FDA IDE approval for a pivotal clinical trial in spinal fusion ...

Should tariffs on pharmaceutical imports go into effect as President Trump is intimating, it would cause U.S. drug prices to ...

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

With the potential for pharmaceutical import tariffs spurring a rush of life sciences investments in the U.S., AbbVie is ...

Since then, the 340B program has allowed Johnson County Hospital to purchase certain drugs from pharmaceutical companies at a ...

Health system pharmacists and physicians are monitoring a wave of expected new drug approvals between late 2024 and third quarter of 2025. A recent article published in the American Journal of ...

SHANGHAI (Reuters) -The Beijing-based American Chamber of Commerce said on Friday that companies in the pharmaceutical sector ...

Families say it's 'completely frustrating' that children with Duchenne Muscular Dystrophy are being denied access to free ...